Fay (dba Fay Nutrition), a leader in digital nutritional therapy, announced a $50 million Series B funding round led by Goldman Sachs at a $500 million valuation.
Existing investors General Catalyst and Forerunner also participated in the round.
This latest investment brings Fay’s total funding to $75 million, following its $25 million Series A round in 2024.
“Our AI-driven platform gives dietitians ‘superpowers,’ automating burdens like insurance claims, scheduling, and patient follow-ups so they can focus on providing intimate and thoughtful care. By analyzing vast amounts of information, our platform helps dietitians craft more precise, personalized journeys for their clients, including supplement recommendations, hyper-curated shopping carts, and lab analyses to drive prevention initiatives for employers and insurers,” says Sammy Faycurry, Co-Founder and CEO.
Fay’s rapid growth and success are largely driven by strategic relationships with employers, physicians, and payors. Over the past year, Fay has expanded its reach to increasingly serve top employers like Amazon, Microsoft, and Pepsi, ensuring that employees at these companies have access to expert dietitian care covered by insurance.